ArticleBritish journal of cancer2024

Losartan rewires the tumor-immune microenvironment and suppresses IGF-1 to overcome resistance to chemo-immunotherapy in ovarian cancer.

Yao Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.